263 related articles for article (PubMed ID: 28336160)
1. Unexpected drug-induced Raynaud phenomenon: Analysis from the French national pharmacovigilance database.
Bouquet É; Urbanski G; Lavigne C; Lainé-Cessac P
Therapie; 2017 Oct; 72(5):547-554. PubMed ID: 28336160
[TBL] [Abstract][Full Text] [Related]
2. [Drug-induced pancreatitis. A review of French spontaneous reports].
Chebane L; Bagheri H; Hillaire-Buys D; Géniaux H; Yahioui N; Laroche ML; Cottin J; Spreux A; Mosquet B; Pecriaux C; Bellet F; Lambert A; Montastruc JL
Rev Med Interne; 2015 Sep; 36(9):573-8. PubMed ID: 26045335
[TBL] [Abstract][Full Text] [Related]
3. [Adverse drug reactions in pediatrics: Experience of a regional pharmacovigilance center].
Saint-Martin C; Kanagaratnam L; de Boissieu P; Azzouz B; Abou Taam M; Trenque T
Therapie; 2016 Oct; 71(5):467-473. PubMed ID: 27203165
[TBL] [Abstract][Full Text] [Related]
4. [Serious adverse drug reactions with tramadol reported to the French pharmacovigilance database between 2011 and 2015].
Moulis F; Rousseau V; Abadie D; Masmoudi K; Micallef J; Vigier C; Pierre S; Dautriche A; Montastruc F; Montastruc JL
Therapie; 2017 Dec; 72(6):615-624. PubMed ID: 28755832
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced progressive multifocal leukoencephalopathy: a case/noncase study in the French pharmacovigilance database.
Colin O; Favrelière S; Quillet A; Neau JP; Houeto JL; Lafay-Chebassier C; Pérault-Pochat MC;
Fundam Clin Pharmacol; 2017 Apr; 31(2):237-244. PubMed ID: 27736027
[TBL] [Abstract][Full Text] [Related]
6. [Comparative relevance of declaration of side effects by patients and health professionals].
Lagneau A; Vigier C; Marianna A; Serfaty R; Rocher F; Spreux A; Drici MD
Therapie; 2017 Dec; 72(6):625-633. PubMed ID: 28780021
[TBL] [Abstract][Full Text] [Related]
7. Safety profile of etifoxine: A French pharmacovigilance survey.
Cottin J; Gouraud A; Jean-Pastor MJ; Dautriche AD; Boulay C; Geniaux H; Auffret M; Bernard N; Descotes J; Vial T
Fundam Clin Pharmacol; 2016 Apr; 30(2):147-52. PubMed ID: 26588183
[TBL] [Abstract][Full Text] [Related]
8. Drugs and Sleep Apneas? A review of the French Pharmacovigilance database.
Linselle M; Montastruc F; Jantzen H; Valnet-Rabier MB; Haramburu F; Coquerel A; Gouraud A; Perault-Pochat MC; Bagheri H; Montastruc JL
Therapie; 2015; 70(4):347-50. PubMed ID: 25679185
[TBL] [Abstract][Full Text] [Related]
9. Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors: a case/non-case study from the French Pharmacovigilance Database.
Faillie JL; Babai S; Crépin S; Bres V; Laroche ML; Le Louet H; Petit P; Montastruc JL; Hillaire-Buys D;
Acta Diabetol; 2014; 51(3):491-7. PubMed ID: 24352344
[TBL] [Abstract][Full Text] [Related]
10. [Drugs and retinal disorders: A case/non-case study in the French pharmacovigilance database].
Bourgeois N; Chavant F; Lafay-Chebassier C; Leveziel N; Pérault-Pochat MC
Therapie; 2016 Sep; 71(4):365-74. PubMed ID: 27203167
[TBL] [Abstract][Full Text] [Related]
11. The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.
Raschi E; Poluzzi E; Salvo F; Koci A; Suling M; Antoniazzi S; Perina L; Hazell L; Moretti U; Sturkenboom M; Garbe E; Pariente A; De Ponti F
Drug Saf; 2016 Jan; 39(1):59-68. PubMed ID: 26446144
[TBL] [Abstract][Full Text] [Related]
12. Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database.
Lugardon S; Lapeyre-Mestre M; Montastruc JL
Eur J Clin Pharmacol; 2004 Nov; 60(9):673-7. PubMed ID: 15517227
[TBL] [Abstract][Full Text] [Related]
13. [Fibrates and risk of venous thromboembolism: Case/no-case study in French pharmacovigilance database].
Humbert X; Dolladille C; Sassier M; Valnet-Rabier MB; Vial T; Guitton E; Page A; Sole E; Auriche P; Coquerel A; Alexandre J; Fedrizzi S
Therapie; 2017 Dec; 72(6):677-682. PubMed ID: 28941579
[TBL] [Abstract][Full Text] [Related]
14. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
[TBL] [Abstract][Full Text] [Related]
15. [Adverse drug reactions (ADRs) to antimalarial drugs. Analysis of spontaneous report from the French pharmacovigilance database (1996-2000)].
Angles A; Bagheri H; Montastruc JL; Magnaval JF;
Presse Med; 2003 Jan; 32(3):106-13. PubMed ID: 12610379
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced retroperitoneal fibrosis: a case/non-case study in the French PharmacoVigilance Database.
Brasselet D; Chouchana L; Vial T; Damin-Pernik M; Lebrun-Vignes B
Expert Opin Drug Saf; 2020 Jul; 19(7):903-914. PubMed ID: 32374194
[TBL] [Abstract][Full Text] [Related]
17. Drugs associated with restless legs syndrome: a case/noncase study in the French Pharmacovigilance Database.
Perez-Lloret S; Rey MV; Bondon-Guitton E; Rascol O; Montastruc AJ;
J Clin Psychopharmacol; 2012 Dec; 32(6):824-7. PubMed ID: 23131889
[TBL] [Abstract][Full Text] [Related]
18. Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance database.
Laroche ML; Quelven I; Mazère J; Merle L
Ann Pharmacother; 2015 Jan; 49(1):39-47. PubMed ID: 25366341
[TBL] [Abstract][Full Text] [Related]
19. Investigating the link between drug consumption and adverse events reporting in France.
Orhon P; Robert M; Morand T; Cracowski JL; Khouri C
Fundam Clin Pharmacol; 2023 Aug; 37(4):879-882. PubMed ID: 36908067
[TBL] [Abstract][Full Text] [Related]
20. Notoriety bias in a database of spontaneous reports: the example of osteonecrosis of the jaw under bisphosphonate therapy in the French national pharmacovigilance database.
de Boissieu P; Kanagaratnam L; Abou Taam M; Roux MP; Dramé M; Trenque T
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):989-92. PubMed ID: 24737486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
